{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T13:40:33Z","timestamp":1793281233587,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007313","name":"The University of Texas MD Anderson Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007313","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["1NU58DP007156"],"award-info":[{"award-number":["1NU58DP007156"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007568","name":"Urology Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007568","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005595","name":"University of California","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["euoncology.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Oncology"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.euo.2024.01.011","type":"journal-article","created":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T21:18:17Z","timestamp":1706822297000},"page":"1069-1079","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Association of Age with Non\u2013muscle-invasive Bladder Cancer: Unearthing a Biological Basis for Epidemiological Disparities?"],"prefix":"10.1016","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6505-8399","authenticated-orcid":false,"given":"Niyati","family":"Lobo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhigang","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akshay","family":"Sood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei Shen","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Grajales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Contieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sia V.","family":"Lindskrog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Dyrskj\u00f8t","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon H.","family":"Giordano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen B.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly K.","family":"Bree","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3546-9928","authenticated-orcid":false,"given":"Ashish M.","family":"Kamat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euo.2024.01.011_b0005","unstructured":"Global Cancer Observatory. GLOBOCAN 2020v1.0, cancer incidence and mortality worldwide. IARC cancer base no. 11. Lyon, France: International Agency for Research on Cancer. http:\/\/globocan.iarc.fr."},{"key":"10.1016\/j.euo.2024.01.011_b0010","unstructured":"National Cancer Institute. Cancer stat facts: bladder cancer. SEER. https:\/\/seer.cancer.gov\/statfacts\/html\/urinb.html."},{"key":"10.1016\/j.euo.2024.01.011_b0015","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21708","article-title":"Cancer statistics","volume":"72","author":"Siegel","year":"2022","journal-title":"Cancer J Clin"},{"key":"10.1016\/j.euo.2024.01.011_b0020","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.eururo.2007.10.006","article-title":"Prognostic factors in patients treated with bacillus Calmette-Guerin: multivariate analysis of data from four randomized CUETO trials","volume":"53","author":"Fernandez-Gomez","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2024.01.011_b0025","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.eururo.2014.06.040","article-title":"Prognostic factors and risk groups in T1G3 non-muscle-invasive bladder cancer patients initially treated with bacillus Calmette-Guerin: results of a retrospective multicenter study of 2451 patients","volume":"67","author":"Gontero","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2024.01.011_b0030","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.eururo.2020.12.033","article-title":"European Association of Urology (EAU) prognostic factor risk groups for non\u2013muscle-invasive bladder cancer (NMIBC) incorporating the WHO 2004\/2016 and WHO 1973 classification systems for grade: an update from the EAU NMIBC Guidelines Panel","volume":"79","author":"Sylvester","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2024.01.011_b0035","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.eururo.2021.08.010","article-title":"European Association of Urology guidelines on non-muscle-invasive Bladder Cancer (Ta, T1 and carcinoma in situ)","volume":"81","author":"Babjuk","year":"2022","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2024.01.011_b0040","doi-asserted-by":"crossref","first-page":"431.e7","DOI":"10.1016\/j.urolonc.2023.05.019","article-title":"Underutilization of intravesical chemotherapy and immunotherapy for high grade non-muscle invasive bladder cancer in California between 2006\u20132018: effect of race, age and socioeconomic status on treatment disparities","volume":"41","author":"Noel","year":"2023","journal-title":"Urol Oncol"},{"key":"10.1016\/j.euo.2024.01.011_b0045","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.urology.2019.03.035","article-title":"Care quality and variability in the use of intravesical therapy for initial treatment of non-muscle invasive bladder cancer within a large diverse integrated delivery system","volume":"131","author":"Danforth","year":"2019","journal-title":"Urology"},{"key":"10.1016\/j.euo.2024.01.011_b0050","doi-asserted-by":"crossref","first-page":"89.e81","DOI":"10.1016\/j.urolonc.2017.11.010","article-title":"Impact of age on outcomes of patients with non-muscle-invasive bladder cancer treated with immediate postoperative instillation of mitomycin C","volume":"36","author":"Xylinas","year":"2018","journal-title":"Urol Oncol"},{"key":"10.1016\/j.euo.2024.01.011_b0055","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1038\/s41467-021-22465-w","article-title":"An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer","volume":"12","author":"Lindskrog","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.euo.2024.01.011_b0060","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ccell.2016.05.004","article-title":"Comprehensive transcriptional analysis of early-stage urothelial carcinoma","volume":"30","author":"Hedegaard","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.euo.2024.01.011_b0065","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","article-title":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data","volume":"43","author":"Quan","year":"2005","journal-title":"Med Care"},{"key":"10.1016\/j.euo.2024.01.011_b0070","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.annepidem.2007.03.011","article-title":"A refined comorbidity measurement algorithm for claims-based studies of breast, prostate, colorectal, and lung cancer patients","volume":"17","author":"Klabunde","year":"2007","journal-title":"Ann Epidemiol"},{"key":"10.1016\/j.euo.2024.01.011_b0075","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1002\/cncr.28147","article-title":"Recurrence of high-risk bladder cancer: a population based analysis","volume":"119","author":"Chamie","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.euo.2024.01.011_b0080","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/j.celrep.2014.04.038","article-title":"Mutational context and diverse clonal development in early and late bladder cancer","volume":"7","author":"Nordentoft","year":"2014","journal-title":"Cell Rep"},{"key":"10.1016\/j.euo.2024.01.011_b0085","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1158\/0008-5472.CAN-22-2912","article-title":"The cytidine deaminase APOBEC3G contributes to cancer mutagenesis and clonal evolution in bladder cancer","volume":"83","author":"Liu","year":"2023","journal-title":"Can Res"},{"key":"10.1016\/j.euo.2024.01.011_b0090","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.eururo.2018.08.027","article-title":"Molecular subtypes of urothelial bladder cancer: results from a meta-cohort analysis of 2411 tumors","volume":"75","author":"Tan","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2024.01.011_b0095","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.cell.2013.05.039","article-title":"The hallmarks of aging","volume":"153","author":"Lopez-Otin","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.euo.2024.01.011_b0100","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1038\/s41416-019-0721-1","article-title":"Cancer as a disease of old age: changing mutational and microenvironmental landscapes","volume":"122","author":"Laconi","year":"2020","journal-title":"Br J Can"},{"key":"10.1016\/j.euo.2024.01.011_b0105","first-page":"1161","article-title":"Innate immunity in aging: impact on macrophage function","author":"Plowden","year":"2004","journal-title":"Aging Cell"},{"key":"10.1016\/j.euo.2024.01.011_b0110","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.it.2016.03.005","article-title":"Aging: a temporal dimension for neutrophils","volume":"37","author":"Adrover","year":"2016","journal-title":"Trends Immunol"},{"key":"10.1016\/j.euo.2024.01.011_b0115","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/s41585-022-00611-3","article-title":"Bladder cancer, inflammageing and microbiomes","volume":"19","author":"Martin","year":"2022","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.euo.2024.01.011_b0120","doi-asserted-by":"crossref","first-page":"e223050","DOI":"10.1001\/jamanetworkopen.2022.3050","article-title":"Management, surveillance patterns, and costs associated with low-grade papillary stage Ta non-muscle-invasive bladder cancer among older adults, 2004\u20132013","volume":"5","author":"Bree","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.euo.2024.01.011_b0125","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1016\/j.juro.2011.12.056","article-title":"National practice patterns for immediate postoperative instillation of chemotherapy in non-muscle-invasive bladder cancer","volume":"187","author":"Cookson","year":"2012","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2024.01.011_b0130","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.urology.2020.07.023","article-title":"Increased bacillus Calmette-Gu\u00e9rin treatment intensity associated with improved outcomes in elderly patients with non\u2013muscle-invasive bladder cancer in United States clinical practice","volume":"145","author":"Richards","year":"2020","journal-title":"Urology"},{"key":"10.1016\/j.euo.2024.01.011_b0135","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1200\/JOP.2011.000480","article-title":"Adjuvant intravesical bacillus Calmette-Gu\u00e9rin therapy and survival among elderly patients with non\u2013muscle-invasive bladder cancer","volume":"9","author":"Spencer","year":"2013","journal-title":"J Oncol Pract"},{"key":"10.1016\/j.euo.2024.01.011_b0140","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/bju.16127","article-title":"Impact of age >70 years on oncological outcomes in patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Guerin","volume":"133","author":"Contieri","year":"2024","journal-title":"BJU Int"},{"key":"10.1016\/j.euo.2024.01.011_b0145","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.1007\/s00345-020-03130-1","article-title":"Analysis of age influence on oncological results and toxicity of BCG immunotherapy in non-muscle-invasive bladder cancer","volume":"38","author":"Krajewski","year":"2020","journal-title":"World J Urol"},{"key":"10.1016\/j.euo.2024.01.011_b0150","doi-asserted-by":"crossref","first-page":"e678","DOI":"10.1016\/S2666-7568(21)00260-9","article-title":"Older patients with cancer: evidence-based care needs evidence","volume":"2","author":"Longevity","year":"2021","journal-title":"Lancet Healthy Longev"}],"container-title":["European Urology Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931124000361?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931124000361?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T23:34:59Z","timestamp":1727220899000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2588931124000361"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S2588931124000361"],"URL":"https:\/\/doi.org\/10.1016\/j.euo.2024.01.011","relation":{},"ISSN":["2588-9311"],"issn-type":[{"value":"2588-9311","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of Age with Non\u2013muscle-invasive Bladder Cancer: Unearthing a Biological Basis for Epidemiological Disparities?","name":"articletitle","label":"Article Title"},{"value":"European Urology Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euo.2024.01.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 European Association of Urology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}